Precision BioSciences's total assets for Q1 2026 were $143.89M, a decrease of -6.82% from the previous quarter. DTIL total liabilities were $67.79M for the fiscal quarter, a 9.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.